U.S. Stock SEC Cash-Flow Directory / Industrials

NRCAvoid

NRC Health Common Stock · Services-Commercial Physical & Biological Research

TFE Standardized Verdict
Avoid
Impersonal model classification
Official SEC Free Cash Flow
$7.0M
SEC Form 10-Q (filed 2026-11-04)
Trend Episodes
Building Up
Multi-episode price & volume path
vs. S&P 500 Benchmark
Leading S&P 500
Relative leadership check
Counterpoint — What Independent Investors Should Watch Out For

Tight Short-Term Liquidity or Negative Gross Margin

Short-term obligations exceed liquid current assets (0.64x current ratio vs. 0.75x minimum floor), alongside $98.1M in long-term debt and +$7.0M free cash flow.

3 Plain-English Questions to Ask Before Buying or Holding NRC:
  • Why are NRC's multi-week price-and-volume trend episodes currently breaking down (Leading S&P 500) despite headline popularity?
  • What downside exit rule protects my portfolio if NRC's current breakdown continues?
  • Are there stronger Industrials companies generating positive SEC Free Cash Flow with healthier trend support right now?

Official U.S. SEC EDGAR Filing Snapshot (NRC)

Period Ended 2026-09-30 · Filed 2026-11-04
Revenues
$38.4M
Gross Margin
54.6%
Operating Cash Flow
$8.0M
Capital Spending (CapEx)
$1.0M
Free Cash Flow
$7.0M
Current Ratio
0.64x
Long-Term Debt
$98.1M
Subscriber Research Workbench • Founding 1000 Launch Offer

See All 46 Industrials Stocks Rated Accumulate Right Now

Every TFE Accumulate stock requires verified positive SEC Free Cash Flow, constructive multi-episode trend durability, and S&P 500 relative strength. Unlock the full 254-stock Accumulate roster, full 2,400+ stock Screener, and personal Watchlist.

Claim Founding 1000 Access — $25 / Full Year →One-time 12-month pass (capped at 1,000 members) · Or $9.99/mo
Check Other Popular U.S. Stocks:
AMZN SEC Checkup →NVDA SEC Checkup →AAPL SEC Checkup →GOOGL SEC Checkup →MSFT SEC Checkup →COST SEC Checkup →PLTR SEC Checkup →KO SEC Checkup →Browse All 2,728 Stocks →

Research Disclosure: Standardized impersonal model publication for research use only — not personalized investment advice and not a brokerage site. Verify all filings and live quotes independently before making investment decisions.